As T2D is often associated with having a high body mass index, one would be forgiven for assuming that the needs of people who use GLP-1s for weight loss and those using it to treat diabetes would be very similar, but recent market research suggests a number of significant differences:5 The majority of people using GLP-1s for weight loss are in their 30s to 50s (often as part of a wider strategy to be proactive about their health), whereas those using GLP-1s for diabetes control are more likely to be over 60
Wang L, Zehir A, Sadowska J, Zhou N, Rosenblum M, Busam K, Agaram N, Travis W, Arcila M, Dogan S, Berger MF, Cheng DT, Ladanyi M, Nafa K, Hameed M
"While your body naturally produces GLP-1, some people may benefit from medications that mimic its effects." That's where injectables like Ozempic come in
Genetic predispositions provide metabolic context but do not predict exact peptide response
Rebate Retention : Every time a prescription for the medication is filled, the PBM receives the agreed-upon rebate from the manufacturer
Its an excellent way to stay proactive in maintaining your health